Mutations of the von Hippel–Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma

Treatment selection for patients with metastatic renal cell carcinoma

(2010) Michael B. Atkins et al.   CANCER

Hereditary kidney cancer

(2010) W. Marston Linehan et al.   CANCER

Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer

(2010) P J Wysocki et al.   CANCER GENE THERAPY

Cytokine Secretion Is Distinct from Secretion of Cytotoxic Granules in NK Cells

(2010) E. Reefman et al.   JOURNAL OF IMMUNOLOGY

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma

(2009) J-J Patard et al.   BRITISH JOURNAL OF CANCER

Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts

(2009) Ebru Urcan et al.   DENTAL MATERIALS

Renal cell carcinoma

(2009) Brian I Rini et al.   LANCET

Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model

(2009) Vassilis Aggelis et al.   PROTEOMICS

Genetic and Epigenetic Alterations in the von Hippel-Lindau Gene: the Influence on Renal Cancer Prognosis

(2008) K. M. Smits et al.   CLINICAL CANCER RESEARCH

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

(2008) Jean-Jacques Patard et al.   INTERNATIONAL JOURNAL OF CANCER

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

(2008) Susan Gilfillan et al.   JOURNAL OF EXPERIMENTAL MEDICINE